rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Kabra Drugs Ltd. - Research Center
524322 KABRADG Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Ratios
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Per share ratios
Adjusted EPS (Rs) -0.76 -0.42 -0.41 -0.13 -0.37
Adjusted cash EPS (Rs) -0.76 -0.39 -0.33 -0.06 -0.30
Reported EPS (Rs) -0.76 -0.42 -0.41 -0.13 -0.37
Reported cash EPS (Rs) -0.76 -0.39 -0.33 -0.06 -0.30
Dividend per share - - - - -
Operating profit per share (Rs) -0.78 -0.39 -0.33 -0.06 -0.31
Book value (excl rev res) per share EPS (Rs) -1.67 -0.89 -0.47 -0.06 0.07
Book value (incl rev res) per share EPS (Rs) -1.67 -0.89 -0.47 -0.06 0.07
Net operating income per share EPS (Rs) - - - 0.05 -
Free reserves per share EPS (Rs) - - - - -
Profitability ratios
Operating margin (%) - - - -120.97 -
Gross profit margin (%) - - - -259.49 -
Net profit margin (%) - - - -264.09 -
Adjusted cash margin (%) -5,299.23 - - -125.57 -1,400.06
Adjusted return on net worth (%) - - - - -516.87
Reported return on net worth (%) - - - - -516.87
Return on long term funds (%) - - - - -331.81
Leverage ratios
Long term debt / Equity - - - - 0.50
Total debt/equity - - - - 20.97
Owners fund as % of total source -112.32 -62.14 -29.98 -4.43 4.55
Fixed assets turnover ratio - - - 0.03 -
Liquidity ratios
Current ratio 13.35 7.52 1.96 1.74 1.79
Current ratio (inc. st loans) 0.24 0.33 0.55 0.65 0.67
Quick ratio 13.35 7.52 1.96 1.74 1.79
Inventory turnover ratio - - - 0.03 -
Payout ratios
Dividend payout ratio (net profit) - - - - -
Dividend payout ratio (cash profit) - - - - -
Earning retention ratio 100.00 100.00 100.00 100.00 100.00
Cash earnings retention ratio - - - - -
Coverage ratios
Adjusted cash flow time total debt - - - - -
Financial charges coverage ratio - - - -26.31 -22.05
Fin. charges cov.ratio (post tax) - - - -26.31 -22.05
Component ratios
Material cost component (% earnings) - - - - -
Selling cost Component - - - - -
Exports as percent of total sales - - - - -
Import comp. in raw mat. consumed - - - - -
Long term assets / total Assets - - 0.01 0.02 0.05
Bonus component in equity capital (%) - - - - -
Close
Add Kabra Drugs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Kabra Drugs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close